“…Among these, DNAzymes, unlike other agents based on protein enzymes, consist only of DNA strands and are composed of a catalytic domain that exhibits catalytic activity by binding with a cofactor metal cation and binding domains that can bind to substrate RNA. Due to these characteristics of DNAzyme, it has the advantage of having high specificity and flexibility compared to other agents. , In particular, DNAzyme has higher physiological stability than siRNA and has higher gene-silencing efficiency than ASO, which relies on the activity of endogenous RNase H . In addition, DNAzymes have advantages such as low immunogenicity, low cost, and easy functionalization. , Due to these excellent properties, DNAzyme has already been applied to gene therapy for various diseases caused by mutations in genes such as cancer, cardiovascular disease, and viral infection …”